Oruka Therapeutics Inc
NASDAQ:ORKA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
US |
|
A
|
Apex Critical Metals Corp
CNSX:APXC
|
CA |
|
J Sainsbury PLC
F:SUY
|
UK |
|
C
|
Canadian Imperial Bank of Commerce
XMUN:CAI
|
CA |
|
NextNav Inc
NASDAQ:NN
|
US |
|
M
|
Mitsubishi Electric Corp
DUS:MIE1
|
JP |
|
Medistim ASA
LSE:0OCD
|
NO |
|
P
|
Pick N Pay Stores Ltd
SWB:PIK
|
ZA |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
I
|
ITV PLC
OTC:ITVPY
|
UK |
|
G
|
Gaztransport et Technigaz SA
F:9TG
|
FR |
|
Lindbergh SpA
F:D8M
|
IT |
|
A
|
Apex Material Technology Corp
TPEX:6899
|
TW |
|
S
|
Sprott Inc
F:A781
|
CA |
|
Serica Energy PLC
LSE:SQZ
|
UK |
Bankruptcy Probability
Oruka Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oruka Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
4.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oruka Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oruka Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.